Synthesis and structure–activity relationships of novel pyrrolocarbazole lactam analogs as potent and cell-permeable inhibitors of poly(ADP-ribose)polymerase-1 (PARP-1)
- 1 March 2006
- journal article
- research article
- Published by Elsevier BV in Bioorganic & Medicinal Chemistry Letters
- Vol. 16 (5), 1151-1155
- https://doi.org/10.1016/j.bmcl.2005.11.086
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- Activating the PARP-1 Sensor Component of the Groucho/ TLE1 Corepressor Complex Mediates a CaMKinase IIδ-Dependent Neurogenic Gene Activation PathwayCell, 2004
- NAD+-Dependent Modulation of Chromatin Structure and Transcription by Nucleosome Binding Properties of PARP-1Cell, 2004
- Poly(ADP-ribose) polymerase inhibitors as potential chemotherapeutic agentsBiochemical Society Transactions, 2004
- Poly(ADP-ribosyl)ation inhibitors: Promising drug candidates for a wide variety of pathophysiologic conditionsInternational Journal of Cancer, 2004
- Pharmacological Modulation of Poly(ADP-ribose) Polymerase-Mediated Cell Death: Exploitation in Cancer ChemotherapyMolecular Pharmacology, 2003
- Chromatin Loosening by Poly(ADP)-Ribose Polymerase (PARP) at Drosophila Puff LociScience, 2003
- The Therapeutic Potential of Poly(ADP-Ribose) Polymerase InhibitorsPharmacological Reviews, 2002
- Mediation of Poly(ADP-Ribose) Polymerase-1-Dependent Cell Death by Apoptosis-Inducing FactorScience, 2002
- The world according to PARPTrends in Biochemical Sciences, 2001
- Inactivation of the Poly(ADP-ribose) Polymerase Gene Affects Oxygen Radical and Nitric Oxide Toxicity in Islet CellsOnline Journal of Public Health Informatics, 1995